Menu UNITED KINGDOM UK Our Impact Being open and transparent Being open and transparent We believe in maintaining high standards in how we promote our medicines, and in being transparent in how we work We are committed to sharing details of our relationships with patient organisations, healthcare professionals and appropriate administrative staff; as well as details of all donations and grants provided to institutions, organisations or associations that are composed of healthcare professionals and/or that provide healthcare or conduct research. Click here for Teva’s methodological note on disclosures for the 2020 year. Support for healthcare professionals and healthcare organisations during 2015 and each subsequent calendar year is published on the Association of the British Pharmaceutical Industry (ABPI) central platform on 30 June of the following year. Disclosure of patient organisation support 2020 disclosures Organisation Registration number Website Details Amount The Migraine Trust 1081300 Click here To support the organisation’s charitable objectives £3,727 The Migraine Trust 1081300 Click here Sponsorship of 2020 MTIS virtual congress (€70,000) £62,005 Patient organisations and patient advocacy We believe in the value of relationships to develop a deeper understanding of patient needs. Because we believe in the value of our relationships with patient organisations, we work hard to develop a deeper understanding of patient needs and to integrate such insights throughout our organisation. In this way, we create transparent partnerships that are central to our work of supporting patients and their caregivers on the journey to improved health and happy lives. Teva Guiding Principles for Patient Organisation Engagement: Ethical Conduct & Integrity Teva personnel are expected to maintain the highest standards of integrity in their relations with patient organisations. Transparency Teva will be open and transparent regarding relationships with patient organisations. Teva will publicly disclose financial support and significant non-financial support provided to patient organisations. Further, patient organisations may publish Teva’s support of their programs as they deem appropriate. Teva’s global policy on patient organisation engagement is available to patient groups. Mutual Benefit Teva’s support of patient organisations is focused on improving the welfare of patients, families and caregivers. Any activity undertaken with patient organisations must clearly demonstrate benefit to the patients whose interests the patient groups represent. Successful partnerships between patient organisations and Teva must provide mutual benefit to both organisations. Therefore, Teva will seek to build mutually beneficial relationships with patient organisations in areas where there is alignment around objectives and priorities. Independence A patient organisation in partnership with Teva must not have its independence compromised, nor should it be perceived to be compromised, and patient organisations retain the right to publicly object to the positions of the company. Compliance Every interaction between company personnel (and its representatives) and patient organisations will comply with all government rules, regulations and guidelines, as well as with all applicable Teva policies. Non-Promotion Teva must not use interactions and relationships with patient organisations to promote its products or increase commercial awareness of its products, except in countries that allow Direct to Consumer Advertising, and only when done in compliance with all applicable laws and Teva policies governing product promotion. Contributions to patient organisations Teva’s contributions to patient organisations last year, to support these organisations in delivering their respective goals and objectives, are published on our corporate website here. This report will be updated annually. Leading a responsible business We ensure all activities are carried out ethically and transparently Discover more Contributing to healthy communities We recognize our responsibility to help address pressing healthcare challenges Learn more Environmental, Social & Governance Report (ESG) We align our corporate resources and expertise with relevant areas of global health and social need Learn more Date of preparation: August 2021 Reference: COB-GB-NP-00048 Contacts Contact us Reporting side effects Teva worldwide Clinical trials Website Information Terms and conditions Privacy policy Pharmacovigilance privacy policy Accessibility About Latest news COVID 19 Modern Slavery Act Follow Teva Facebook Twitter Linkedin Linkedin Registered in England No. 302461. Registered office: Teva UK Limited, Whistler Drive, Castleford, WF10 5HX We would like to collect some of your data to enhance your browsing experience, analyse, and measure your engagement with our content. By clicking [Accept] you consent to this and to sharing this data with our partners, including to serve you more relevant ads on other websites. If you continue without accepting, this cannot take place or will be less accurate. You can change your mind at any time. To find out more about your rights, our practices, the data we collect and our partners, click here. Reject All Accept Your Choices